Abstract
Onychomycoses are disseminated worldwide with a prevalence of 2%–13% or even more in special groups of the population [1–6]. Fungal infections of the nail may occur at any age, but they are very rare in children. They are mainly observed in adults and the number of cases in elderly people is increasing rapidly [7]. Considering the relatively high prevalence and the steadily increasing incidence, onychomycosis should no longer be regarded as a merely cosmetic problem. Onychomycosis may be caused by a variety of fungal agents, including dermatophytes, yeasts and moulds. Infections tend to occur more often in patients with underlying diseases, such as circulatory disorders or diabetes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Degreef H (1990) Onychomycosis. Br J Clin Pract 44[Suppl 71]:91–97
Ramesh V et al (1993) Onychomycosis. Int J Dermatol 22:148–152
Andre J, Achten G (1987) Onychomycosis. Int J Dermatol 26:481–490
Walshe MM et al (1966) Fungi in nails. Br J Dermatol 78:198–207
Heikkila H et al (1995) The prevalence of onychomycosis in Finland. Br J Dermatol 133:699–703
Gupta A et al (1997) Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists’ offices in Ontario, Canada: a multicenter survey of 2001 patients (poster). Conference of the Am Acad Dermatol, San Francisco
Hanecke E (1991) Fungal infections of the nail. Semin Dermatol 10:41–53
Seebacher C et al (1993) Batrafen Nagellack bei Onychomykosen. Multicenterstudie bei 1239 Patienten. Hautnah Mykologie 3:80–84
Friederich HC, Effendy I (1990) Zur Behandlung von Onychomykosen mit Nagel Batrafen (internal clinical report)
Effendy I (1991) Stellenwert einer antimykotischen Lokalbehandlung bei Onychomykosen. Hautnah Derm 2:72–84
Effendy I, Luders R (1998) Erfolgreiche Onychomykose-Therapie mit Nagel Batrafen (internal clinical report)
Nolting S, Lassus A (1988) Wirksamkeit und Verträglichkeit von Ciclopirox-Lackzube-reitung (8%)—Nagel Batrafen—bei der Behandlung von Onychomykosen (internal clinical report)
Adam W et al (1990) Verschiedene Lackgrundlagen mit 8%igem Ciclopirox. Vergleich der Wirksamkeit und Verträglichkeit (internal clinical report)
Ehlers G, Hubner K (1990) Wirksamkeit und Verträglichkeit von Ciclopirox (8%) in einer Lackzubereitung (internal clinical report)
Tai LJ (1991) Traitement de 302 onychomycoses. Efficacite d’un vernis a ongle de ciclopirox a 8% en ouvert (internal clinical report)
Xu WY, Wu S (1989) Clinical experience with 8% ciclopirox nail lacquer in the treatment of onychomycoses (internal clinical report)
Yu B et al (1991) A clinical and laboratory study of ciclopirox nail lacquer (8%) in the treatment of onychomycoses. Chin Med Sci J 6:166–168
Baran R et al (1991) Effect of a 8% ciclopirox antifungal lacquer in onychomycosis: a multicenter, double-blind clinical trial versus systemic ketoconazole (abstract 182). 2nd Congress European Academy of Dermatology and Venerology (EADV). Athens, Oct 10-13
Tai LJ, Wu S, Yu B (1991) Internal clinical study report
Seebacher C, Leonhardt H-G, Horn W (1993) Ciclopirox nail varnish for onychomycosis (internal clinical biométrie report)
Gupta AK, Sander DN, Shear NS (1994) Antifungal agents: an overview. Part 11. J Am Acad Dermatol 30:911–933
Seebacher C (1993) Onychomyleosen—eine therapeutische Herausforderung für Arzt und Patient. Fortschr Med 111[Suppl 139]:7–8
Nolting S, Seebacher C (1993) Ciclopirox olamin: Wegweiser topischer Mykose-Therapie. Universitätsverlag Jena GmbH, Jena, p 61
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Nolting, S. (1999). Open Studies of Ciclopirox Nail Lacquer in Onychomycosis—A Review. In: Shuster, S. (eds) Hydroxy-Pyridones as Antifungal Agents with Special Emphasis on Onychomycosis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-58401-5_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-58401-5_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-65494-0
Online ISBN: 978-3-642-58401-5
eBook Packages: Springer Book Archive